SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

GLTO is trending due to significant pre-market price action and high trading volume, reminiscent of recent runs by other stocks like SPRB. The community is actively discussing potential reasons for the surge, including a possible short squeeze and comparing it to other high-flying tickers. Some traders are noting the lack of specific news catalysts while others speculate about possible undisclosed developments related to its oncology and liver disease treatments.

NuCana Plc is a clinical stage biopharmaceutical company. It engages in the business of developing a portfolio of new medicines to treat patients with cancer. The company was founded by Hugh Stephen Griffith and Christopher Barry Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.

NuCana plc - ADR

NuCana plc

NuCana ($NCNA) is trending as investors discuss its low float, recent Nasdaq compliance, and upcoming presentation at ESMO in October, with some drawing parallels to previous low-float runners like $SPRB. Community members are speculating on a potential short squeeze and anticipating news, while highlighting the company's cash runway into 2029.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is seeing increased volatility, with community chatter focused on whether a significant downturn is imminent. Mixed sentiment abounds, with some traders taking profits and anticipating a larger correction, while others are buying the dip expecting a quick recovery. News impacting AI-related stocks and broader economic concerns like inflation and government shutdowns also appear to be influencing market sentiment.

Ethereum is a global, open-source platform for decentralized applications. In other words, the vision is to create a world computer that anyone can build applications in a decentralized manner; while all states and data are distributed and publicly accessible. Ethereum supports smart contracts in which developers can write code in order to program digital value. Examples of decentralized apps (dapps) that are built on Ethereum includes tokens, non-fungible tokens, decentralized finance apps, lending protocol, decentralized exchanges, and much more.  On Ethereum, all transactions and smart contract executions require a small fee to be paid. This fee is called Gas. In technical terms, Gas refers to the unit of measure on the amount of computational effort required to execute an operation or a smart contract. The more complex the execution operation is, the more gas is required to fulfill that operation. Gas fees are paid entirely in Ether (ETH), which is the native coin of the blockchain. The price of gas can fluctuate from time to time depending on the network demand.

Ethereum

Ethereum is trending amid discussions of potential short squeezes and its struggle to break resistance, with community members debating its near-term trajectory. Bullish arguments center on institutional adoption via staking ETFs and upcoming network upgrades, while bears point to historical patterns and potential pullbacks. The conversation also touches on Ethereum's role in tokenization and its relationship with other cryptocurrencies like Bitcoin.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

$TMC is trending as the deep-sea mining sector gains traction, with community members discussing potential short squeezes and a possible breakout. Optimism is fueled by anticipation of government partnerships and regulatory approvals, particularly the NOAA decision. Bullish investors are focused on the company's long-term potential in the critical minerals market.

Trilogy Metals, Inc. engages in the development and exploration of mineral properties. The firm holds interests in the Upper Kobuk mineral projects that include the Arctic, a copper-zinc-lead-gold-silver and Bornite, a carbonate-hosted copper projects, which is located in the Ambler mining district in Northwest Alaska. The company was founded on April 27, 2011 and is headquartered in Vancouver, Canada.

Trilogy Metals Inc

Trilogy Metals is trending after the U.S. government announced a major investment, acquiring a 10% stake to support mining exploration in Alaska. The community is actively discussing the potential for a short squeeze and a run to double-digit prices, though some caution against a potential sell-off. This news comes amid a broader push to bolster domestic mineral resources.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending as community members assess the stock's performance following recent financial guidance and earnings. Despite increased long-term revenue and EPS growth forecasts driven by AI infrastructure demand, some are concerned about profit margins and the stock's reaction. Discussions include whether the positive outlook justifies the current stock price and comparing Dell's potential with other AI-related stocks.

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

Spruce Biosciences ($SPRB) is trending due to significant price action following positive news regarding FDA breakthrough therapy designation, sparking considerable discussion among traders. The community highlights the stock's low float and potential for further gains, drawing comparisons to other high-momentum stocks. Some caution against chasing the rally, while others anticipate a potential buyout given the relatively low market cap.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors await the distribution of warrants, sparking debates about their potential value and impact, with some expressing frustration over delays and brokerages. The community is also actively discussing Ryan Cohen's strategy and potential catalysts, while others criticize perceived manipulation and the stock's performance relative to the broader market. Talk of a short squeeze and the company's long-term prospects remains prevalent.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is seeing active discussion around AI's influence and potential overextension, with some traders pointing to Oracle's recent data as a sign of hype while others cite new deals with AMD, Nvidia, and OpenAI as bullish catalysts. Community members are debating the sustainability of the rally and the impact of the government shutdown, with a focus on technical levels and potential pullbacks. Recent price action and analyst targets continue to fuel both bullish and bearish perspectives.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$QNTM https://www.globenewswire.com/news-release/2025/10/02/3160289/0/en/Quantum-BioPharma-Receives-Final-Reports-for-Two-Key-Studies-of-its-Potential-Breakthrough-Drug-for-Multiple-Sclerosis-Moving-Closer-to-Phase-2-Clinical-Trial.html

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the...

GlobeNewswire News Room

Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial